BioNTech Indemnitees has the meaning set forth in Section 15.1 (Indemnification by Genevant).
BioNTech Indemnitees has the meaning set forth in Section 9.6(b).
BioNTech Indemnitees has the meaning set forth in Section 9.6(b). 1.51 "Solely Owned IP" has the meaning set forth in Article 5. 1.52 "Sublicensee" means any Third Party that is granted a sublicense as permitted by Section 2.2, either directly by BioNTech or its Affiliates or indirectly by any other Sublicensee hereunder. 1.53 “Target” means the proteins described in Appendix 1.53 and includes: (a) [***] naturally occurring human protein [***]. 1.54 "Technology" means collectively Patents and Know-How. 1.55 "Term" has the meaning set forth in Section 10.1. 1.56 "Territory" means worldwide. 1.57 "Third Party" means any person or entity other than BioNTech, Acuitas and their respective Affiliates. 1.58 "Third Party Claims" has the meaning set forth in Section 9.6(a). 1.59 “Vaccine” means any product primarily intended (i) to elicit an adaptive immune response in the recipient against a specific disease-causing organism or malignancy as the result of presentation of antigen(s) associated with the disease-causing organism or malignancy; or (ii) to provide passive immune protection against a specific disease-causing organism. 1.60 “Vaccine Target” means Covid-19 Target as described in Appendix 1.53. 1.61 "Valid Claim" means, with respect to a particular country, any claim of (i) an issued and unexpired Patent; or (ii) a pending Patent claim, [***]
Examples of BioNTech Indemnitees in a sentence
Disputes arising under or in connection with this License Agreement will be resolved pursuant to this Section 11.1; provided, however, that in the event a dispute cannot be resolved without an adjudication of the rights or obligations of a Third Party (other than any BioNTech Indemnitees or Acuitas Indemnitees identified in Section 9.6), the dispute procedures set forth Sections 11.1(c) and 11.1(c) will be inapplicable as to such dispute.
There are no express or implied third party beneficiaries hereunder (except for BioNTech Indemnitees and Acuitas Indemnitees for purposes of Section 9.6).
More Definitions of BioNTech Indemnitees
BioNTech Indemnitees has the meaning set out in Section 16.1.
BioNTech Indemnitees has the meaning set forth in Section 12.2 (Indemnification of BioNTech by Biotheus);
BioNTech Indemnitees has the meaning set out in Section 16.1. 1.48 “Biosimilar Product” means, in a particular country with respect to a particular [***] Licensed Product, a product that: (a) has received all necessary approvals by the applicable Regulatory Authorities in such country to place on the market such product as a biopharmaceutical product; (b) is marketed or sold by a Third Party that has not obtained the rights to such product as a Sublicensee or distributor of, or through any other contractual relationship with, BioNTech or any of its Affiliates or Sublicensees; and (c) is approved as a “biosimilar” (in the United States) or a “similar biological medicinal product” (in the EU) or using a comparable procedure in other countries whereby the [***] Licensed Product is the “reference medicinal product” and an expedited Regulatory Approval process for the approval of generic versions of biological products is used based on Applicable Laws and once all regulatory exclusivities and intellectual property rights for the [***] Licensed Product have expired. 1.49 “[***]” means [***]. 1.50 “BNT211” has the meaning set out in Section 3.1(a). 1.51 “Business Day” means a day other than a Saturday, Sunday, or a bank or other public holiday in London, England or Mainz, Germany. 1.52 “Calendar Quarter” means the respective periods of three (3) consecutive calendar months ending on March 31, June 30, September 30 and December 31; provided, that: (a) the first Calendar Quarter of the Term shall extend from the Effective Date to the end of the first such three (3)- month period thereafter; and (b) the final Calendar Quarter of the Term shall extend from the first day of such three (3)-month period until the last day of the Term.